Influence of surface properties at biodegradable microsphere surfaces: Effects on plasma protein adsorption and phagocytosis

Pharmaceutical Research

Volumn 15, Issue 2, 1998, Pages 312-317

  Lacasse, F X ^a   Filion, M C ^a   Phillips, N C ^a   Escher, E ^b   McMullen, J N ^a   Hildgen, P ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Microspheres; PEG; Phagocytosis; Plasma protein adsorption

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN ANTAGONIST; CYTOCHALASIN D; MACROGOL; MICROSPHERE; PLASMA PROTEIN;

ADSORPTION; ANIMAL CELL; ARTICLE; BIODEGRADATION; CONTROLLED RELEASE FORMULATION; LASER MICROSCOPY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SURFACE PROPERTY;

ADSORPTION; ANIMALS; BLOOD PROTEINS; CELL SURVIVAL; FEMALE; LACTIC ACID; MACROPHAGES; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PHAGOCYTOSIS; POLYGLYCOLIC ACID; POLYMERS; SURFACE PROPERTIES;

EID: 0031939804     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011935222652     Document Type: Article

References (29)

1. J. Heller. Bioerodable systems. In R. Langer and D. Wise (eds), Medical Applications of Controlled Release, CRC Press, Boca Raton, FL, 69-102 (1984).
2. D. H. Lewis. Controlled release of bioactive agents from lactide/glycolide polymers. In M. Chasin, R. Langer, (eds). Biodegradable Polymers as Drug Delivery Systems. New York: Marcel Dekker, 1-41 (1990).
3. Y. Tabata, S. Gutta, and R. Langer. Pharm. Res. 10(4):487-496 (1993).
4. Y. Tabata and R. Langer. Pharm. Res. 10(3):391-399 (1993).
5. C. C. Mylonas, Y. Tabata, R. Langer, and Y. Zohar. J. Control. Rel. 35:23-34 (1995).
6. E. Mathiowitz, W. M. Saltzman, A. Domb, and R. Langer. J. Appl. Polym. Sci. 35:755-774 (1988).
7. B. W. Wagenaar and B. W. Müller. Biomaterials 15(1):49-54 (1994).
8. W. Dang, T. Daviau, and H. Brem. Pharm. Res. 13(5):683-691 (1996).
9. B. Gander, P. Johanssen, H. Nam-Tran, and H. P. Merkle. Int. J. Pharm. 129:51-61 (1996).
10. B. Gander, E. Werhli, R. Alder, and H. P. Merkle. J. Microencapsulation. 12(1):83-97 (1995).
11. C. Bitz and E. Doelker. Int. J. Pharm. 131:171-181 (1996).
12. J. W. Fong. French Patent no. FRA 81 11694, (1981).
13. W. C. Hueper. Arch. Pathol. 67:589-617 (1959).
14. G. Gregaoriadis. Liposomes as Drug Carriers: Recent Trend and Progress, Wiley, New York, (1993).
15. S. M. Moghimi and H. M. Patel. FEBS Lett. 233:143-147 (1988).
16. H. Kwaguchi and N. Koiwai. Biomaterials. 7:61-66 (1986).
17. T. M. Allen, G. A. Austin, A. Chonn, L. Lin, and K. C. Lee. Biochem. Biophys. Acta. 1061(1):56-64 (1991).
18. J. Senior, C. Delgado, D. Fisher, C. Tilcock, and G. Gregoriadis. Biochem. Biophys. Acta. 1062(1):77-82 (1991).
19. S. Zalipsky. Adv. Drug. Deliv. Rev. 16:157-182 (1995).
20. S. Stolnik, L. Illum, and S. S. Davis. Adv. Drug Deliv. Rev. 16:195-214 (1995).
21. N. Privitera, R. Naon, P. Vierling, and J. G. Riess. Int. J. Pharm. 120:73-82 (1995).
22. N. C. Phillips and S. Heydari. Pharm. Sci. 2:73-76 (1996).
23. J. H. Ratcliffe, I. M. Huneyball, A. Smith, C. Wilson, and S. S. Davis. J. Pharm. Pharmacol. 36:431-436 (1984).
24. F. X. Lacasse, P. Hildgen, J. Pérodin, N. C. Phillips, E. Escher, and J. N. McMullen. Pharm. Res. 14(7):887-891 (1997).
25. K. M. Shakesheff, C. Evora, I. Soriano, and R. Langer. J. of Colloid & Interface Sci. 185(2):538-547 (1997).
26. N. V. Hud, F. P. Milanovich, and R. Balhorn. Biochem. 33(24):7528-7535 (1994).
27. M. E. Norman, P. Williams, and L. Illum, Biomaterials. 13(12):841-849 (1992).
28. A. Chonn, S. C. Semple, and P. R. Cullis. Biochim. Biophys. Acta. 1070(1):215-222 (1991).
29. D. V. Devine, K. Wong, A. Chonn, and P. R. Cullis, Biochim. Biophys. Acta. 1191(1):43-51 (1994).